Nanomedicine is increasingly used in applications like
drug delivery and diagnosis, with promising results in several
fields, including oncology, cardiology and immunology. However, the
rising popularity of nanobiomaterials (NBMs) also raises questions
about their potential adverse effects on the environment after
excretion and release.
Assessing the risks associated with nanoparticles in medical
applications

